For some heart failure patients, a treatment known as EECP is a beneficial option, but it requires a commitment.
Jane Racey Gleeson
Jane Racey Gleeson has been a member of the University of Michigan Frankel Cardiovascular Center’s communications team as a contributing writer for the past three years. She works with the team to produce targeted communications that meet the Frankel CVC’s goals. Gleeson’s 30 years in the technical communications field extend to custom publications, website development and integrated marketing for a variety of clients. She received her bachelor’s degree with honors in journalism from Oakland University in Rochester, Michigan.
A barber was faced with giving up his beloved profession because of severe pain from PAD. How a Michigan Medicine team helped him get back to work.
Heart failure with preserved ejection fraction is unique to each individual, requiring a personalized treatment plan and closely monitored care.
How cross-system collaboration yielded a positive outcome for one bicuspid aortic valve patient — and what others can learn from his experience.